Reply to 'Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?'

Nat Commun. 2021 Mar 19;12(1):1729. doi: 10.1038/s41467-021-21950-6.

¹ Sohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine, the Rappaport Faculty of Medicine and Research Institute, Technion‒Israel Institute of Technology, Haifa, Israel.
² McEwen Center for Regenerative Medicine, University Health Network, Toronto, ON, Canada.
³ Sohnis Research Laboratory for Cardiac Electrophysiology and Regenerative Medicine, the Rappaport Faculty of Medicine and Research Institute, Technion‒Israel Institute of Technology, Haifa, Israel. [email protected].
⁴ Cardiology Department, Rambam Health Care Campus, Haifa, Israel. [email protected].

No abstract available

Publication types